Abstract
Objective
To determine maternal and fetal outcomes of women complicated with hyperthyroidism compared with those in normal pregnant women.
Materials and methods
This cohort study was conducted on singleton pregnant women complicated by hyperthyroidism without other medical complications between January 1994 and December 2008, at tertiary center. The normal controls were identified to match the cases with the ratio of 2:1. The baseline characteristics as well as maternal and fetal outcomes were analyzed and compared for pregnancy outcomes.
Results
Of the 203 pregnant women diagnosed for hyperthyroidism, 180 cases met the inclusion criteria, and 360 controls were matched. The activity of the disease was controlled to be euthyroid state in most cases. Maternal complications were comparable between both groups except that the study group had potentially higher incidence of pregnancy-induced hypertension. The mean gestational age (±SD), and mean birth weight were significantly lower in the study group. The incidence of fetal growth restriction, fetus with low birth weight and preterm births were significantly higher in the study group with a relative risk of 1.3, 1.4, and 1.3, respectively.
Conclusion
Pregnant women with hyperthyroidism were significantly associated with an increased risk of fetal growth restriction, preterm birth and low birth weight and had a tendency to have a higher rate of pregnancy-induced hypertension.
Similar content being viewed by others
References
ACOG Practice Bulletin (2002) Clinical management guidelines for obstetrician-gynecologists. Number 37, August 2002. (Replaces Practice Bulletin Number 32, November 2001). Thyroid disease in pregnancy. Obstet Gynecol 100(2):387–396
Davis LE, Lucas MJ, Hankins GD, Roark ML, Cunningham FG (1989) Thyrotoxicosis complicating pregnancy. Am J Obstet Gynecol 160(1):63–70
Lim BH, Raman S, Sivanesaratnam V, Ngan A (1989) Thyrotoxicosis in pregnancy–a six year review. Singapore Med J 30(6):539–541
Kriplani A, Buckshee K, Bhargava VL, Takkar D, Ammini AC (1994) Maternal and perinatal outcome in thyrotoxicosis complicating pregnancy. Eur J Obstet Gynecol Reprod Biol 54(3):159–163
Millar LK, Wing DA, Leung AS, Koonings PP, Montoro MN, Mestman JH (1994) Low birth weight and preeclampsia in pregnancies complicated by hyperthyroidism. Obstet Gynecol 84(6):946–949
Laurberg P, Bournaud C, Karmisholt J, Orgiazzi J (2009) Management of Graves’ hyperthyroidism in pregnancy: focus on both maternal and foetal thyroid function, and caution against surgical thyroidectomy in pregnancy. Eur J Endocrinol 160(1):1–8
Mestman JH (2004) Hyperthyroidism in pregnancy. Best Pract Res Clin Endocrinol Metab 18(2):267–288
Phoojaroenchanachai M, Sriussadaporn S, Peerapatdit T, Vannasaeng S, Nitiyanant W, Boonnamsiri V et al (2001) Effect of maternal hyperthyroidism during late pregnancy on the risk of neonatal low birth weight. Clin Endocrinol (Oxf) 54(3):365–370
Rosenfeld H, Ornoy A, Shechtman S, Diav-Citrin O (2009) Pregnancy outcome, thyroid dysfunction and fetal goitre after in utero exposure to propylthiouracil: a controlled cohort study. Br J Clin Pharmacol 68(4):609–617
Diav-Citrin O, Ornoy A (2002) Teratogen update: antithyroid drugs-methimazole, carbimazole, and propylthiouracil. Teratology 65(1):38–44
Srisupundit K, Sirichotiyakul S, Tongprasert F, Luewan S, Tongsong T (2008) Fetal therapy in fetal thyrotoxicosis: a case report. Fetal Diagn Ther 23(2):114–116
Conflict of interest statement
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Luewan, S., Chakkabut, P. & Tongsong, T. Outcomes of pregnancy complicated with hyperthyroidism: a cohort study. Arch Gynecol Obstet 283, 243–247 (2011). https://doi.org/10.1007/s00404-010-1362-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-010-1362-z